HomeDXCM • SWX
add
DexCom Inc
Market cap
25.56B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.26B | 13.12% |
Gastos sa pagpapatakbo | 469.70M | 0.60% |
Net na kita | 267.30M | 76.20% |
Net profit margin | 21.22 | 55.80% |
Kita sa bawat share | 0.68 | 51.11% |
EBITDA | 388.20M | 57.36% |
Aktuwal na % ng binabayarang buwis | 21.54% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.00B | -22.51% |
Kabuuang asset | 6.34B | -2.23% |
Kabuuang sagutin | 3.59B | -17.98% |
Kabuuang equity | 2.75B | — |
Natitirang share | 384.86M | — |
Presyo para makapag-book | — | — |
Return on assets | 11.67% | — |
Return on capital | 17.10% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 267.30M | 76.20% |
Cash mula sa mga operasyon | 294.00M | -2.46% |
Cash mula sa pag-invest | 306.60M | 200.95% |
Cash mula sa financing | -1.52B | -95,037.50% |
Net change in cash | -917.80M | -5,978.15% |
Malayang cash flow | 85.75M | -42.68% |
Tungkol
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
11,050
